Pax Extends High-End Cannabis Vaporizer Line with Introduction of Era


Pax Labs is extending its premium product line to take advantage of the trend towards cannabis concentrates by introducing the Pax Era vaporizer. The product, which retails for $59.99, is being sold only in California and Colorado initially and will work with only its own pods that will be sold by authorized partners. Most of the industry uses standard cartridges for oil vaporizers.

Pax has selected very highly regarded partners as the initial retailers of the pods, including California’s Bloom Farms and Colorado’s The Clinic. Bloom Farms will be selling the cartridges for $40 and is offering three different Pax Era Pods, Indica+, Hybrid+ and Sativa+. Bloom Farms will donate one healthy meal to one of its California-based food bank partners for every PAX Era Pod sold. The Clinic, which operates 5 Colorado stores and is also in Illinois and Nevada, hasn’t yet announced its pricing or initial products.

Update (3 P.M. ET)

Following publication, The Clinic released information about its offering, which includes a live resin extract created by its concentrates production division, The Lab.  The pods, which have a retail price of $60, will be available at not only its own stores but also Medicine Man, Buddy Boy, LivWell Enlightened Health and several other dispensaries.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter